And Pharmaceuticals Health Technology Technical Cooperation for Essential Drugs and Traditional Medicine Challenges of Medicine Regulation in Africa Global.

Slides:



Advertisements
Similar presentations
REGIONALISM: A TRADE STRATEGY FOR AFRICA? Paul Kalenga WTO SYMPOSIUM 21 April 2005.
Advertisements

World Health Organization
VII Conference of the Pan American Network on
Options for national or regional production or procurement Wilbert Bannenberg SARPAM.
Vincent Nkhoma Manager- Enforcement & Exemptions COMESA Competition Commission.
Merton V. Smith, Ph.D., J.D. Director International Programs Center for Veterinary Medicine U.S. Food and Drug Administration Governance of Veterinary.
AFRICA REGULATORY CONFERENCE FEEDBACK DR DORCAS PETA 1 JUNE 2012.
The AU Model Law on Medical Products Regulation and Harmonisation
SADC FREE TRADE ARRANGEMENT BENEFITS & OPPORTUNIES Presented by: Sipho Maluleka Department of Agriculture Directorate: International Trade Desk: Africa.
3rd WHO Prequalification Stakeholders Meeting
SERVICES TRADE RESTRICTIONS Transportation Services in SADC.
Regulation of Pharmaceuticals in Kenya
ICH-GCG June 2009 Pan American Health Organization CURRENT STATUS OF PAN AMERICAN NETWORK FOR DRUG REGULATORY HARMONIZATION (PANDRH): James Fitzgerald.
NATIONAL DRUG AUTHORITY - UGANDA | Slide 1 of February 2010, Geneva, Switzerland How the African NMRAs are benefiting from the WHO medicines prequalification.
Putting Coherence in Financing Scheme of Regional and Sub-Regional Organizations and Countries By Ackim Jere SADC Secretariat Gaborone, Botswana Fifth.
1 IMPLEMENTATION OF THE COMESA TRANSIT TRANSPORT FACILITATION INSTRUMENTS Background to Transit Transport Facilitation Instruments in the COMESA Region.
13/06/2008SAPRAA-Salma Ismail FEEDBACK ON AFRICA REGULATORY CONFERENCE FEBRUARY 2008.
Training Workshop on Pharmaceutical Development with a Focus on Paediatric Medicines / October |1 | Prequalification programme: Priority essential.
Options for national/regional production of generic medicines Wilbert Bannenberg, MD MPH Zambia TRIPS workshop 3 Oct 2013.
1 INTERNATIONAL TRADE ARRANGEMENTS SA TRADE AGREEMENTS DIRECTORATE: INTERNATIONAL TRADE NOVEMBER 2010.
Update and future directions for prequalification of medicines WHO HQ, Geneva, 4 February 2008 Dr Lembit Rägo Coordinator Quality Assurance and Safety:
Working with Countries, Harmonisation and Regional Initiatives Technical Briefing Seminar MP Matsoso Director Department of Technical Cooperation for Essential.
Wilbert Bannenberg SARPAM
Options for national/regional production of generic medicines Wilbert Bannenberg, MD MPH Lesotho TRIPS workshop 14 Aug 2014.
QUALITY REPRODUCTIVE HEALTH SUPPLIES Dr Hans V. Hogerzeil Director Essential Medicines & Pharmaceutical Policies.
Regulation of medicines and other health technologies. The future of regulation, where are we going? EMP TBS November 2014, Geneva Dr Lembit Rägo Head,
NRA in BTSs of the EMR Dr. Nabila E. Metwalli Regional Advisor / Blood Safety WHO / EMRO Cairo, Egypt and Dr. Abdel Aziz Saleh WHO / EMRO Advisor.
ACCESS TO MEDICINES - POLICY AND ISSUES
Zambia’s Porous Borders & the Influx of Medicines.
SARPAM Southern African Regional Programme for Access to Medicines and Diagnostics Presentation to Botswana TRIPS and Access to Medicines workshop 26 March.
1 Further Development of Customs Riga, 26 November th Anniversary of the State Revenue Service of Latvia Kunio Mikuriya Secretary General elect.
REGIONAL RESEARCH COOPERATION BY PHUMELELE MAGUBANE DEPUTY DIRECTOR: AFRICAN COOPERATION South Africa/ Norway RESEARCH COOPERATION WORKSHOP CAPE TOWN
Gaps from the Perspective of NGOs/ Foundations/PDPs IoM Workshop: International Regulatory Harmonization Amid Globalization of Biomedical Research & Medical.
Slide 1 of 10D.K. Mubangizi, Dar Es Salaam Sept Training Workshop for Evaluators from National Medicines Regulatory Authorities in East African Community.
Differences in development. Three types of differences in development: local regional global.
Elements of an Effective Regional Strategy for Development of Statistics - SADC Ackim Jere SADC Secretariat Gaborone, Botswana PARIS 21 Forum on Reinforcing.
Investment, Export and Growth in Africa Findings from a Survey of African Employers’ Organisations.
WHO Prequalification of Medicines: a gateway to the global pharmaceutical market Introduction 28 June 2014, Shanghai Milan Smid.
ASEAN Cooperation on Standards and Conformance Background Participation of stakeholders in the ACCSQ activities ACCSQ structure Measures undertaken Progress.
WHO Medicines Strategy Progress: Priorities: Dr Guitelle Baghdadi Essential Drugs and Medicines Policy World Health Organization November.
Group A: Angola – Mozambique – RdC –Mauritius - Kenya G roup B: Namibia – Seychelles - South Africa - Uganda Group C: Botswana - Lesotho – Swaziland -Tanzania.
Implementation of TRIPS Flexibilities In National IP Legislation For Strengthening Access To Medicines In Swaziland Workshop with MOH and stakeholders,
Strategic Objective 4 To promote the exchange of experiences and regulatory knowledge between NRAs inside and outside PANDRH“ Lessons learned from international.
Lahouari Belgharbi, WHO/EMP/HQ THE OBJECTIVES AND DEVELOPMENT OF A JOINT NRA ASSESSMENT TOOL Update on harmonization of WHO/PAHO NRA assessment process.
1 Outcome of the 4 th Global Animal Health Conference (GAHC) June 2015 Bettye K. Walters, DVM US Food and Drug Administration
1 CHALLENGES IN REGULATING QUALITY AND RATIONAL USE OF ANTIBIOTICS ALLIANCE FOR THE PRUDENT USE OF ANTIBIOTICS: INAGURAL MEETING COURTYARD.
The First Conference for Medicines Regulatory Authorities In Sudan and Neighboring Countries Khartoum December 2014 Alain PRAT, Technical Officer,
2010 James Fitzgerald Senior Advisor, Medicines and Health Technologies PAHO/WHO rd St Washington DC USA International Cooperation in Quality.
Steps for the Integration of Traditional Medicine in the National Health Care Delivery System 18 TH ICASA Special Session on Traditional Medicine 1 st.
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
Round Table: Future challenges for PANDRH CARICOM Perspective.
WHO Technical Briefing Seminar
EISA ACE Southern Africa Regional Resource Centre
Wilbert Bannenberg SARPAM
EAST AFRICAN COMMUNITY MEDICINES REGULATORY HARMONIZATION (EAC-MRH) PROJECT PROGRESS NAIROB I - KENYA By: EAC - Secretariat.
Overview of vaccines prequalification
Policy coherence approach in promoting local pharmaceutical manufacturing Int'l High level multi-stakeholders workshop on promoting pharmaceutical investment.
Dr Samvel Azatyan Technical Officer Regulatory Support
Technical Assistance and Capacity Building Activities in SADC
SADC Collaborative Medicines Registration Process (ZAZIBONA)
The Role of Donors in PPD on a Regional Level
SADC FREE TRADE ARRANGEMENT BENEFITS & OPPORTUNIES
East Central and Southern Africa Health Community (ECSA HC)
Regulation of Medical Products & Patient Safety- A Narrative Review
East African Community Efforts to Harmonization Pesticide
Dr Manisha Shridhar Regional Advisor WHO-SEARO
SADC FREE TRADE ARRANGEMENT BENEFITS & OPPORTUNIES
An Enabling Business Environment and A Strategic Collaborative Approach for Sustainable Quality Local Production Africa Pharma Conference 4-5 June 2019,
Africa Pharma Conference 2019
An Enabling Business Environment and A Strategy and Collaborative Approach for Sustainable Quality Local Production Africa Pharma Conference 4-5 June 2019,
Presentation transcript:

and Pharmaceuticals Health Technology Technical Cooperation for Essential Drugs and Traditional Medicine Challenges of Medicine Regulation in Africa Global Pharmaceutical Regulation MP Matsoso

and Pharmaceuticals Health Technology Technical Cooperation for Essential Drugs and Traditional Medicine Evaluation & registration TECHNICAL ELEMENTS Standards Norms Specifications Guidelines Procedures Infrastructure Finance Human resources Policy, legislation, regulations STRUCTURES AND ADMINISTRATIVE ELEMENTS Licensing Manufacturing Import Wholesale Retail Dispensing Premises Practices Persons Generic drugs New drug molecules Clinical trial Inspection Manufacturing New drug molecules Clinical trial Quality control Physico-chemical Microbiological Pharmaceutical Information & Promotion control Safety & Efficacy surveillance District Drugs for human use Functions & Processes LEVEL Central State/province Community Dimensions of Drug Regulation

and Pharmaceuticals Health Technology Technical Cooperation for Essential Drugs and Traditional Medicine Pre-marketing phase Post Marketing phase Market surveillance Market surveillance Inspections Market distribution Clinical trials Ethics, GLP;GMP,GCP) Clinical trials Ethics, GLP;GMP,GCP) Quality Safety Efficacy Product Evaluation Product Evaluation GMP compliance GMP compliance Licensing facility Licensing facility Laboratory testing Laboratory testing Dossier Licensing/Registration= evaluation process Applicants Dossier Marketing Authorization Complexity of Regulatory Processes Safety monitoring Safety monitoring Variations Approval

and Pharmaceuticals Health Technology Technical Cooperation for Essential Drugs and Traditional Medicine Regulatory Gaps: A Global Picture Developed Developing a Developing c1 Developing b LDC/CPA - a LDC/CPA - b 1/6 Developed regulatory systems 1/2 Varying levels of development & operational capacity 1/3 limited or no capacity 193 Member States: Developing c2

and Pharmaceuticals Health Technology Technical Cooperation for Essential Drugs and Traditional Medicine Regulatory Challenges Complexity of Regulatory Processes and requirements has increased Limited regulatory capacities in countries Regulatory delays and backlogs Lack of specific timelines by MRAs Lack of requirements that are publicly available (rapidly evolving technologies, new drug delivery and vaccine delivery technologies) Lack of access to appropriate technology

and Pharmaceuticals Health Technology Technical Cooperation for Essential Drugs and Traditional Medicine Integration among regions: An approach Regional and subregional approaches and global initiatives are considered for: Pooling resources, to deal with capacity challenges, Reducing duplication of effort, redirecting resources Standardizing requirements Streamlining regulatory processes Legal mechanisms to jointly negotiate Promotion of good governance

and Pharmaceuticals Health Technology Technical Cooperation for Essential Drugs and Traditional Medicine The case for harmonisation Initiatives that are considered for pooling resources Global Initiatives : –WHO Prequalification (supports procurement, but has strong regulatory focus) –DCVRN (vaccine regulatory network of 9 countries established by WHO) –EU Article 58, Scientific Opinion for medicines exported from EU but not for sale in EU, partnership with WHO –FDA Tentative approval of PEPFAR linked products, confidentiality agreement with WHO –ICH GCG- Participation of some subregional blocs, SADC, ASEAN, PANDRA

and Pharmaceuticals Health Technology Technical Cooperation for Essential Drugs and Traditional Medicine Technical Package: Registration Submission of Application Product X Authority A Authority B Product development Registration Process Decision Registration Process Decision Application Product X 1 2 Technical package

and Pharmaceuticals Health Technology Technical Cooperation for Essential Drugs and Traditional Medicine Post Marketing: Redirecting resources –Scientific information after the authorization (variations) –Post marketing information on quality –Post marketing information on safety and efficacy –Continuous risk benefit assessment –Strengthened law enforcement capacity

and Pharmaceuticals Health Technology Technical Cooperation for Essential Drugs and Traditional Medicine Opportunities: Harmonisation of Medicine regulation 1.Regulatory package based on WHO guidelines. Assess country and regional capacities and determine roles and functions. 2.Joint assessments, inspections, dossier evaluation and information exchange. 3.Twinning arrangements with more stringent authorities e.g. EMEA, FDA. Maximization of benefits of global initiatives, i.e. Prequalification 4.Harmonize standards and guidelines and medicines lists (paediatrics, reproductive health etc) 5.Strengthen management and administration of regional structures, promote good governance and practices 6.Regional Enforcement activities to fight counterfeits

and Pharmaceuticals Health Technology Technical Cooperation for Essential Drugs and Traditional Medicine SADC/WHO DRA 1 DRA 2 DRA 3 DRA 4 SADC/WHO DRA 1 DRA 3 DRA 2 Sharing basic information: a common data and file repository has been created for participating countries. Limited number of countries for registration package Adding scope and functionality: additional countries participate and make available selected national medicines registration data Shared information repository on regulatory and pharmaceutical activities and data Angola Botswana Democratic Republic of Congo Lesotho Malawi Madagascar Mauritius Mozambique Namibia South Africa Swaziland Tanzania Zambia Zimbabwe

and Pharmaceuticals Health Technology Technical Cooperation for Essential Drugs and Traditional Medicine CEMAC COMESA EAC ECOWAS SADC UEMOA Shared information repository & query system on national registration status of medicines. Connectivity between national registration systems Facilitating harmonization: countries participate in various subregional activities. Some have developed guidelines, subregional harmonisation plans. Subregional assessments give status of a country within a subregion

and Pharmaceuticals Health Technology Technical Cooperation for Essential Drugs and Traditional Medicine Integration among African countries Progress Some countries have removed barriers to trade (e.g. tariffs). May be good to advocate for removal of taxes and tariffs for essential medicines Interconnectivity in terms of transport links and telecommunication (ECOWAS, SADC,CEMAC, UEMOA) Common purpose and collective action Main support from WHO working with Partners Drawbacks Conflicts High disease burden Multiplicity of regional economic communities (duplication, overlaps, waste of scarce resources) Transport costs still too high Slow pace